Cabot Corporation (NYSE:CBT) Stock Has Average Target Price of $87.80 According to Brokerages

Cabot Corporation (NYSE:CBT) has been assigned an average rating of “Hold” from the seven analysts that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $87.80.

CBT has been the subject of several recent research reports. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, October 11th. UBS Group reduced their price objective on Cabot from $92.00 to $86.00 and set a “neutral” rating on the stock in a research note on Monday, October 5th. JPMorgan Chase & Co. upped their price objective on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. Truist Financial set a $100.00 price objective on Cabot in a research note on Wednesday, August 5th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st.

Insiders Place Their Bets

In related news, CEO Sean Keohane sold 134,895 shares of the firm’s stock in a transaction on Friday, August 28th. The stock was sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares in the company, valued at $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last 90 days, insiders sold 229,597 shares of company stock worth $19,646,746. Corporate insiders own 3.08% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Root Financial Partners LLC bought a new position in shares of Cabot during the third quarter valued at approximately $27,000. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Cabot in the second quarter worth approximately $33,000. Rockefeller Capital Management L.P. raised its holdings in shares of Cabot by 115.3% in the fourth quarter. Rockefeller Capital Management L.P. now owns 1,152 shares of the specialty chemicals company’s stock worth $76,000 after buying an additional 617 shares during the period. Global Retirement Partners LLC bought a new stake in shares of Cabot during the 2nd quarter worth approximately $88,000. Finally, Parallel Advisors LLC lifted its stake in shares of Cabot by 10.5% during the 1st quarter. Parallel Advisors LLC now owns 1,843 shares of the specialty chemicals company’s stock worth $139,000 after acquiring an additional 175 shares during the last quarter. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Price Performance

CBT stock opened at $74.57 on Tuesday. Cabot has a 52 week low of $58.33 and a 52 week high of $94.53. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The company has a fifty day simple moving average of $77.98 and a two-hundred day simple moving average of $79.50. The firm has a market capitalization of $3.85 billion, a P/E ratio of 21.01, a price-to-earnings-growth ratio of 8.76 and a beta of 0.83.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. The business had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The business’s revenue was up 6.4% on a year-over-year basis. During the same period last year, the company posted $1.90 EPS. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Analysts anticipate that Cabot will post 6.35 earnings per share for the current fiscal year.

Cabot Company Profile

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.